E-GEOD-51507 - Comparison of microRNA Profiling Platforms (HTS)
Released on 22 October 2013, last updated on 15 April 2014
Global miRNA expression profiling of human malignancies is gaining popularity in both basic and clinically driven research. But to date, the majority of such analyses have used microarrays and quantitative real-time PCR. With the introduction of digital count technologies, such as next-generation sequencing (NGS) and the NanoString nCounter System, we have at our disposal, many more options. To make effective use of these different platforms, the strengths and pitfalls of several miRNA profiling technologies were assessed, including a microarray platform, NGS technologies and the NanoString nCounter System. These results were compared to gold-standard quantitative real-time PCR. Comparison of non-small cell lung cancer cell lines grown in vitro (n = 5) and in vivo (n = 5) as xenograft models.
RNA-seq of non coding RNA
Shirley Tam <email@example.com>, John D McPherson, Ming-Sound Tsao, Richard de Borja
Robust global microRNA expression profiling using next-generation sequencing technologies. Tam S, de Borja R, Tsao MS, McPherson JD. , Europe PMC 24445778